Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRAS(G12D) mutations: a phase 1 trial. (nature.com)

Authors: Ai X … Lu S Journal: Nature Medicine Published: 2026-09-01 DOI: https://doi.org/10.1038/s41591-026-04559-4